XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Net sales $ 712,019 $ 581,113 $ 2,050,002 $ 1,736,824
Cost of sales 400,450 329,613 1,139,738 978,568
Gross profit 311,569 251,500 910,264 758,256
Selling, general and administrative expenses 147,180 117,370 426,708 369,750
Restructuring expenses and asset impairments 3,204 2,917 8,568 6,758
Operating income 161,185 131,213 474,988 381,748
Other expense (income) - net 630 (704) 16,957 7,321
Interest expense 9,498 10,642 31,479 33,958
Income before income taxes 151,057 121,275 426,552 340,469
Provision for income taxes 35,343 17,427 95,987 63,759
Net income 115,714 103,848 330,565 276,710
Net loss attributable to noncontrolling interest 28 0 80 0
Net income attributable to IDEX $ 115,742 $ 103,848 $ 330,645 $ 276,710
Earnings per common share:        
Basic earnings per common share attributable to IDEX (in dollars per share) $ 1.52 $ 1.38 $ 4.35 $ 3.66
Diluted earnings per common share attributable to IDEX (in dollars per share) $ 1.51 $ 1.37 $ 4.33 $ 3.64
Share data:        
Basic weighted average common shares outstanding (in shares) 76,010 75,352 75,957 75,423
Diluted weighted average common shares outstanding (in shares) 76,452 75,960 76,408 76,119